Press release
Global Pain Management Therapeutics Market Expected To Be Worth US$ 83 Billion By 2024
Pain Management Therapeutics Market
The global pain management therapeutics market is expected to exceed US$ 83 billion by 2024, registering a compound annual growth rate (CAGR) of more than 3.5% during the forecast period.
A glimpse of the report structure is provided in the report description available on the website.
https://www.marketresearchengine.com/reportdetails/pain-management-therapeutics-market
Abbott Laboratories, AstraZeneca, Depomed, Inc., Endo Pharmaceuticals, Inc., GlaxoSmithKline plc, Johnson & Johnson, Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Purdue Pharma L.P., and Teva Pharmaceutical Industries Limitedare the most active players in the pain management therapeutics market.
The increase in the incidence of chronic pain disorders, rise in geriatric population with high risk of various diseases, growing adoption of pain management therapeutics among end users, and favorable regulatory scenario and health care reforms are driving the market. However, patent expiry of key drugs and entry of generics, prescription drug abuse, and long-term pain relief from surgical procedures, alternative therapies, and medical devices are hindering the growth of the market.
The Pain management therapeutics Market has been segmented as below:
By Therapeutics Analysis
Antimigraine agents
Non steroidal anti inflammatory drugs
Anesthetics
Antidepressants
Anticonvulsants
Opioids
Tramadol
Hydrocodones
Oxycodaones
Others (Methadone, Meperidine, Fentanyl, Codeine, Morphine)
Other non narcotic analgesic
By Indication Analysis
Cancer pain
Post operative pain
Migraine
Arthritic pain
Chronic back pain
Fibromyalgia
Neuropathic pain
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
This report covers the pain management therapeutics market, in terms of value, and forecasts the market size till 2024. In addition, the report identifies key growth segments and opportunities in the industry. This report also covers detailed competitive outlook including the share and company profiles of the key players in the global market. Company profile includes company summary, financial summary, business strategy and planning, SWOT analysis, and current developments.
Request Sample Report: https://www.marketresearchengine.com/reportdetails/pain-management-therapeutics-market
The deep-dive study on the pain management therapeutics market will help customers with the identification of new market opportunities and targeted promotional plans.
Table of Contents
1. INTRODUCTION
2 Research Methodology
3. Global Pain Management Therapeutics Market – Industry Analysis
4. North America Pain Management Therapeutics Market Revenue, (US$ Mn), 2014–2024
5. Europe Pain Management Therapeutics Market Revenue, (US$ Mn), 2014–2024
6. Asia Pacific Pain Management Therapeutics Market Revenue, (US$ Mn), 2014–2024
7. Rest of World Pain Management Therapeutics Market Revenue, (US$ Mn), 2014–2024
8. Country Snippet
9. Company Profiles
9.1. Abbott Laboratories
9.2. AstraZeneca
9.3. Depomed, Inc.
9.4. Endo Pharmaceuticals, Inc.
9.5. GlaxoSmithKline plc
9.6. Johnson & Johnson
9.7. Mallinckrodt Pharmaceuticals
9.8. Merck & Co., Inc.
9.9. Novartis AG
9.10. Pfizer, Inc.
9.11. Purdue Pharma L.P.
9.12. Teva Pharmaceutical Industries Limited
About Us
Market Research Engine (MRE) is a next-generation provider of syndicated research, customized research, and consulting services. MRE’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each Market Research Engine’s research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Media Contact
Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com/
Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Pain Management Therapeutics Market Expected To Be Worth US$ 83 Billion By 2024 here
News-ID: 774279 • Views: …
More Releases from (MRE) Report
Weight Management Market is Expected To Be Worth US$ 442 Billion By 2025
New York, March 26, 2018:
Weight Management Market 2018
The Global Weight Management Market is expected to exceed more than US$ 442.0 Billion by 2025 at a CAGR of 8.0% in the given forecast period.
The scope of the report includes a detailed study of global and regional markets on Global Weight Management Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed…
Home Healthcare Market is Expected To Be Worth US$ 300 Billion By 2022
New York, March 26, 2018:
Home Healthcare Market 2018
The Global Home Healthcare Market is expected to exceed more than US$ 300.7 Billion by 2022 at a CAGR of 7.4% in the given forecast period.
The scope of the report includes a detailed study of global and regional markets on Global Home Healthcare Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed…
Healthcare 3D Printing Market is Forecast to Cross US$ 4 Billion By 2022
New York, March 26, 2018:
Healthcare 3D Printing Market 2018
The Global Healthcare 3D Printing Market is expected to exceed more than US$ 4 Billion by 2022 at a CAGR of 21.0% in the given forecast period.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include 3D Systems, Arcam AB, Renishaw PLC., EoS…
Tumor Ablation Market is Projected to Reach US$ 650 Million By 2022
New York, March 26, 2018:
Tumor Ablation Market 2018
The Global Tumor Ablation Market is expected to exceed more than US$ 650 Million by 2022 at a CAGR of 12.0% in the given forecast period.
The scope of the report includes a detailed study of global and regional markets for Global Tumor Ablation Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed…
More Releases for Pain
Global Pain Management Devices Market Study Analysis: Adoption Of Pain Managemen …
The fast-food market size was valued at $ billion in 2020 and is estimated to reach $ billion by 2028, growing at a CAGR of 6.3% during the forecast period. Pain is an unpleasant sensation and emotional experience caused due to actual or potential tissue damage or illness. Pain can be caused due to accidental injuries, or due to diseases like osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis, stomach ulcer,…
Flexotone Joint Pain Relief Reviews: Get Relief from Joint Pain & Arthritis
Joint pain & inflammation has come to be an instead usual problem among older consumers, as well as they are frequently entrusted to identify exactly how to deal with these problems with a topical cream or resting. Nevertheless, the makers behind Flexotone think that the reason behind this concern has every little thing to do with something that takes place within the joints. This trouble triggers unbelievable pain; however Big…
Nerve Pain Treatment: 3 Top Neuropathy Pain Relief Pills
Neuropathy affects your extremities or nerves by producing tingling, discomfort, or numbness. Diabetics frequently suffer from neuropathy. According to the American Diabetes Association, around 65 percent of people suffering from diabetes face varying degrees of nerve damage, which results in diabetic neuropathy.
Neuropathy can also occur due to different reasons, like alcoholism, trauma, or autoimmune disorders. Some people acquire neuropathy due to physical injury to their nerves, for instance. Others have…
Post-operative Pain Management Market 2018 by Pain Type - Acute Pain, Moderate P …
Post-operative Pain Management Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Post-operative Pain Management Market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023.
Global Post-operative Pain Management Market - Overview
Post-operative pain management is the most important part…
Opioids – Reducing body pain but increasing pain for regulatory authorities
Opioids are drugs primarily prescribed for pain management and treatment of diarrhea and cough. Opioid drugs are of two types namely, agonist and antagonist. Codeine, Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone, Diphenoxylate, Hydromorphone, Methylphenidate, Oxycodone, and Oxymorphone are classified as agonists, while Buprenorphine, Naloxone, Naltrexone, Methylnaltrexone, and Nalbuphine are classified as antagonists. Due to easy availability of opioids, these drugs are rampantly overused globally and the situation is more critical in…
Middle East Tapentadol Market by Therapeutic Application Pain Management Neuropa …
Tapentadol is an opioid analgesic, indicated for severe pain management, on a daily or around the clock need for treatment and long-term opioid treatment, for which alternative treatment options are inadequate. Tapentadol is also indicated for neuropathic pain associated with diabetic peripheral neuropathy. It is widely used for management of acute, chronic, and cancer related pain among patients and is available legally on prescription. Nucynta ER is the first and…
